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IDENTIFICATION OF A WIDELY DISTRIBUTED 90-kDa GLYCOPROTEIN THAT 
IS HOMOLOGOUS TO THE HERMES-1 HUMAN LYMPHOCYTE HOMING 
RECEPTOR1
STEVEN T. P A L S / FRANS HOGERVORST,f GERRIT D. KEIZER/ THEO THEPEN,+
EVELIENE HORST,* a n d  CARL C. FIGDOR2+
From the * Department of Pathology, Free University, and the + Diulsion of Imrriurology, The N etherlands C ancer Institu te ,
Amsterdam, The Netherlands
Homing of recirculating lym phocytes from th e  
blood into the lymphoid tissu es  is  m ediated by 90- 
kDa homing receptors on the lym phocyte cell sur­
face, allowing selective binding to  specia lized  en ­
dothelium  lining high endothelial venu les. This 
study describes two novel mAb, NKI-P1 and NKI-P2, 
directed against functional ep itopes of a hum an  
lym phocyte homing receptor, gp90. B iochem ical 
studies demonstrated th at th ese  antibodies recog­
nize a 90-kDa glycoprotein w hich is  sim ilar to the  
Ag recognized by the mAb Herm es-1, This notion  
was confirmed by im m unohistochem ical stu d ies  
showing identical reaction patterns. Furthermore, 
it was observed that NKI-P1 and NKI-P2 blocked  
adhesion of lym phocytes to  high endothelia l v en ­
ules. Immunohistochemical, im m unofluorescence, 
and immunoprécipitation stu d ies revealed th at 
gp90 is widely expressed on hem opoietic ce lls  in ­
cluding lym phocytes, m acrophages/dendritic cells, 
myeloid cells, and erythrocytes. The gp90 is  a lso  
expressed on a number of nonhem opoietic cells  
such as endothelial cells, certain ep ithelia l cells, 
and fibroblasts. In addition to  its  expression  on  
normal cells, gp90 is present on a spectrum  of tum or 
cell lines of lymphoid, m onocytic, ep ithelial, glial, 
and m elanocytic origin. In addition to  the 90-kDa 
product, the antibodies im m unoprecipitate several 
polypeptides in the range o f 120 to  200  kDa. Inter­
estingly, it was observed th at certain  m am m a tum or 
cell-line cells lack the 90-kDa polypeptide indicating  
the heterogeneous expression o f th e  m olecu les rec­
ognized by these antibodies- T hese resu lts  indicate  
that the 90-kDa glycoprotein hom ologues of th e  
Hermes-1 human lym phocyte hom ing receptor are 
expressed on hem opoietic tissu es  a s  w ell a s  on a  
number of nonhem opoietic t issu e s  and tum or cell 
lines. Although the function of th ese  m olecu les in  
nonlymphoid cells is presently  unknow n, they  
might play a role in cell-cell or cell-m atrix adhesion .
Cell-adhesion molecules are thought to play a critical
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role in many cellular processes such as growth regula­
tion» cell migration, and organogenesis. In the immune 
system, interactions via Ag specific receptors are re­
quired for the induction and regulation of the immune 
response and for effector cell function. Cell-adhesion 
molecules enhance the efficacy of these specific T lym­
phocyte accessory and T lymphocyte target cell interac­
tions (1, 2). Moreover, they are important for a variety of 
other cell-cell and cell-substrate interactions in the im­
mune system (1-6). Recent studies with mAb that inter­
fere with adhesive cell functions have defined a number 
of these cell-surface molecules. They include the Ag of 
the LFA-13 family, consisting of LFA-1, the C3bi receptor, 
and the p l50 ,95  Ag (1—3); the LFA-3 and CD2 Ag (1, 2); 
the ICAM-1 Ag (2, 7); and the Hermes-1 LHR (5, 8).
The recent identification of different functional do­
mains on the «-chain of LFA-1 (9) and C3bi receptor {10) 
prompted us to attempt to raise new mAb to as yet 
unidentified epitopes on these molecules. To this end 
mice were immunized intrasplenically with immunopre- 
cipitated LFA-1 family Ag. Here we describe two mAb, 
NKI-P1 and NKI-P2, that were obtained by using the 
above protocol. Interestingly, these mAb both immuno- 
precipitated a major product with an m.w. of 90,000 
(gp90), which is distinct from the /3-chain of LFA-1 but 
proved homologous to the Hermes-1 LHR. This Ag is 
widely distributed on cells of both hemopoietic and non­
hemopoietic origin.
MATERIALS AND METHODS
P re p a ra t io n  o f  m A b .  BALB/c mice w ere  im m unized  in t ra s p le n i­
cally  w ith  im m u n o p rec ip ita ted  LFA-1 fam ily Ag. T he  im m unoprec lp - 
i ta te s  w ere  o b ta in ed  from  lysates of h u m a n  m onocytes (>95% pure  
a s  de tec ted  by s ta in in g  for nonspecific  esterase) ob ta ined  by c e n tr i f ­
ugal é lu tr ia t io n  (11). Im m unopréc ip ita tions  were carried  o u t w ith  
th e  a n tic o m m o n  /3-chain an tibody CLB-LFA1 / I  (12) a n d  th u s  yielded 
all th r e e  LFA-1 fam ily  Ag. F our days a f te r  th e  th ird  im m unization , 
sp leen  cells w ere  fu sed  w ith  S P 2 /0  m yelom a cells a n d  h y b rid o m a 
s u p e r n a ta n t s  w ere  sc reen ed  for reactivity  w ith  h u m a n  m onocy tes  
by in d irec t im m unofluo rescence . In addition  s u p e rn a ta n ts  were 
te s ted  for th e i r  effect on  JY  cell aggregation. Two positively reac tin g  
h y b rid o m as  w ere  c loned  fourfold by lim iting dilution an d  w ere  d e s ­
ig n a ted  NKI-P1 (IgGl) a n d  NKI-P2 (IgGl), T h e  m Ab SPV-L7 (IgGl), 
SPV-L10 (IgGl), NKI-L15 (IgG2a) specific fo r the LFA-1« s u b u n i t  
w ere  ra ised  in our labo ra to ry  (13). F u r th e rm o re  w e used CLB-LFA- 
1/1 (IgGl) specific  fo r th e  0 su b u n it  of LFA-1 (12), W 6 /3 2  (lgG2a) 
specific  fo r  a  n o n p o ly m o rp h ic  d e te rm in a n t of HLA-ABC (14) a n d  
15D9 (IgGl) specific  fo r T 2 0 0  (Dr. R. v an  Lier, C en tra l L abora to ry  of 
th e  N e th e r la n d s  Red C ro ss  Blood T ra n s fu s io n  Service, A m sterdam ). 
H e rm e s -1 (rat IgG2a), w h ich  reac ts  w ith  th e  H erm es-1 h u m a n  LHR
3 Abbreviations used in this paper: HEV, high endothelial venule; LFA-
1, leukocyte function associated antigen-1; LHR, lymphocyte homing 
receptor; JY, Epsteln-Barr virus transformed B cell.
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(15), was k indly  provided by Dr. B u tch e r  (D epartm ent of Pathology, 
S tan fo rd  University, S tan fo rd , CA).
A ggrega tion  a s s a y .  JY  cells w ere  seeded in 96-well fia tbottom  
m icro tite r  p lates (no. 3596, Costar, Cam bridge, MA). E ach  well con­
ta in ed  1.5 x  10s cells, previously w ash ed  an d  resuspended  in  Iscove’s  
m edium  con ta in ing  10% FCS. The m A b w ere  added (1000-fold dilu­
tion  of ascites) and  th e  p la tes  w ere  stored  fo r various tim e periods 
a t  37°C. The percen tage  of aggregated cells w as de te rm ined  as  
described (9).
R ad io la b e ltn g t im m u n o p réc ip i ta t io n ,  a n d  SD S-PAG E a n a ly s is .  
Two m ethods were used fo r cell su rface  radioiodination, th e  iodogen 
m ethod  or the  lactoperoxidase m ethod. For im m unoprécip ita tion , 
labeled cells w ere lysed a t  4°C (1 h) w ith  1% Nonidet P-40 in 0.01 M 
tr ie th an o l am ine-H C l pH 7.8 , 0 .15  M NaCl, 1 mM pheny lm ethy lsu l-  
fonyl fluoride, 0 .02  m g/m l ovomucoid trypsin  inh ib ito r (Sigma, St. 
Louis, MO). After rem oval of in so lub le  m ateria l, the  lysate  w as  
precleared  successively w ith  m ouse  IgG coupled to pro te in  A sepha- 
rose  a n d  protein  A sep h aro se  itself. T he  precleared  lysa tes  w ere 
incuba ted  w ith  specific mAb, coupled, an d  crosslinked  to p ro te in  A 
sepharose  for 2 to 3 h  a t  4°C. T he  im m unoprec ip ita tes  w ere w ash ed  
w ith  lysis bu ffer con ta in ing  0.5% Nonidet P-40 (Sigma). SDS-PAGE 
w as  carried  out according to th e  Laem m li procedure (16). Kodak SAR 
film w as used in com bination  w ith  in ten s if ie r  sc reens  fo r  au to rad i­
ography.
P ep tid e  m a p p in g  u s in g  S. a u r e u s  V8 p ro tea se .  Polypeptide gel 
b a n d s  w ere cut out of a fixed an d  dried  gel a n d  swollen in  0 .125  M 
Tris-HCl buffer (pH 6.8), 0.1% SDS, 1 mM EDTA. The slices w ere 
loaded upon  a  second polyacry lam ide gel an d  overlayed w ith  Tris 
bu ffe r  con ta in ing  10% glycerol a n d  1 fig V8 pro tease  (ICN, Plainview , 
NY). E lectrophoresis w as  s topped  fo r 30 m in  w h en  th e  dye f ro n t  
reached  th e  beg inning  of th e  ru n n in g  gel. After th is  in cu b a tio n  
period, w hich  w as perform ed a t  room  tem pera tu re , e lec trophoresis  
w as  continued.
Im m u n o p e ro x id a se  s ta in in g .  S ta in in g  w as  perform ed on  aceton- 
fixed cryosta t sec tions by a n  ind irec t im m unoperoxidase  procedure. 
T h e  serial frozen sec tions  w ere in cu b a ted  w ith  NKI-P1 or H erm es-1 , 
w ashed , an d  incubated  w ith  h o rse rad ish  peroxidase conjugated rab- 
b it-an ti-m ouse IgG (DAKO) in  th e  p resence  of 5% no rm al h u m a n  
serum . Subsequently , th e  sec tions w ere  w eak ly  co u n te rs ta in ed  w ith  
hem atoxylin .
Jn vitro H E V -b ind ing  a s s a y .  T h e  in  v itro  b ind ing  of h u m a n  
lym phocytes to HEV w as  assayed  a s  described  previously (6, 17). In 
brief, fresh ly  cu t 10-fim c ryosta t sec tions of norm al o r reactive 
periphera l lym phnodes w ere  incuba ted  fo r 30  m in  a t  4°C w ith  1.10G 
norm al h u m a n  PBL in 100 /¿I H EPES-buffered R PM I1640 co n ta in in g  
5% new born  calf se rum  on m icroprin t s tock  slides (diam eter 8  mm, 
CL301, Nucaton, Newfield, NJ). T he  PBL or th e  frozen sec tions w ere 
pre incubated  w ith mAb for 60 m in  a t  4°C in  RPMI 1640 con ta in ing  
50 ¿ig/ml cyclohexamide, a n d  w ashed . T h e  sections w ere ag ita ted  
during  incubation. Subsequen tly , they  w ere fixed in 1% g lu tara lde- 
hyde an d  exam ined u n d e r  d a rk  field illum ination to identify HEV- 
ad h eren t cells. H E V -adheren t cells were quantified  per s ta n d a rd  
u n it HEV length by m e a n s  of a  g raph ic  tab le t  fitted  to a  m icrocom ­
pu ter (MOP-videoplan, K ontron , Eching, FRG). All sam ples  w ere 
assayed in  triplicate. T h e  a d h e re n c e  of m A b-trea ted  lym phocytes 
w as expressed as  a  percen tage  of th e  contro l (no an tibody added), 
an d  from these da ta  th e  percen tage  of inh ib ition  w as calculated.
Cell l in es  a n d  cell cu lture .  T h e  cell lines used  are: JY, A 375 , M l 4 
(hum an melanomas), T24 (hum an  b ladder carcinom a), OVCAR-4 
(hum an ovarian  carcinom a), U87MG (glioblastoma), U 937 (promon- 
ocytlc cell line), MCF-7, ZR75, an d  T47D, (hum an  m am m ae arc i nom a 
cell lines), and  HBL100, a  no rm al h u m a n  m am m ary  g land  cell line. 
T hese  cell lines w ere cu ltu red  in  iscoves m edium  (GIBCO, G rand  
Island, NY) supplem ented  w ith  10% h e a t  inactivated  FCS, penicillin , 
an d  streptom ycin, The cell lines w ere  regularly  tested  for m ycoplasm  
con tam ination .
Im m uno fluorescence .  Single cell su sp en s io n s  w ere incuba ted  (30 
min, 4°C) in  PBS con ta in ing  1% BSA (Boehringer, M annheim , FRG)
0.01% sodium  azide an d  a  500-fold dilu tion of mAb ascites. After 
w ash ing  fluorescein iso th iocyanate  labeled goat F(ab ')2 an ti-m o u se  
IgG antibody (Tago, Inc., Burlingam e, CA) w as  added for 30  m in  a t  
4°C. F luorescence in ten s ity  w as m easu red  w ith  a  FACS.
RESULTS
Hybridomas were produced from mice immunized in- 
trasplenically with immunoprecipitated LFA-1 family Ag. 
Selection on reactivity with human monocytes by im­
munofluorescence yielded two hybridomas, NKI-P1 and 
NKI-P2.
NKI-P1 and NKI-P2 stimulate homotypic aggregation
of J Y  cells. Inasmuch as mAb against functional epitopes 
of the LFA-1 a- and /5-chain inhibit both the spontaneous 
and PMA-induced homotypic interactions of JY cells, we 
studied the possible inhibitory effect of supernatants 
from NKI-P1 and NKI-P2 on this interaction. Surpris­
ingly, we found tha t mAb secreted by the hybridomas 
NKI-P1 and NKI-P2 did not inhibit but, in contrast, stim­
ulated the aggregation of the LFA-1 positive cell line JY 
(Table I). As expected mAb against LFA-1 a or the com­
mon ¡3 subunit strongly inhibited the aggregation (Table 
I). A control mAb against HLA class-1, which is abun­
dantly expressed by JY cells, did not affect aggregation 
(Table I).
NKI-P1 and NKÏ-P2 immunoprectpitate a major prod­
uct with an m .w . of 90,000 (gp90) distinct from  the 13- 
chain of LFA-1. The mAb secreted by NKI-P1 and NKI- 
P2 immunoprecipitated from monocytes a major product 
with an m.w. of 90,000 (gp90), and variable amounts of 
120, 150, and 180 kDa products (Fig. 1, lane A and B). 
In all of the immunoprécipitations carried out, the 90- 
kDa band was the most prominent by far. These products 
are not disulfide-linked because the same pattern is ob­
served under reducing and nonreducing conditions, al­
though the individual bands migrate slightly faster under 
nonreducing conditions, indicating that some intramole­
cular disulfide bonds are present. The 95-kDa /3-subunit 
of LFA-1 (Fig. 1, lane C and D) was clearly distinct from 
gp90 in that the latter molecule migrates as a broad band 
with an m.w. slightly lower than  LFA-10 (Fig. 1).
gp90 is homologous to the Hermes-1 LHR. Unexpect­
edly we observed that the immunohistochemical staining 
pattern of sections of human lymphoid tissues with the 
mAb NKI-P1 and NKI-P2 was identical to the pattern 
obtained with Hermes-1, a recently described mAb di­
rected against a 90-kDa Ag involved in the binding of 
human lymphocytes to HEV (data not shown). To further 
investigate the possibility tha t NKI-P1 and NKI-P2 rec­
ognized the Hermes-1 LHR, we tested the capacity of 
these mAb to interfere with the in vitro binding of human 
PBL to HEV. As shown in Table II, both mAb inhibit 
binding of lymphocytes to peripheral lymphnode HEV, 
Inhibition occurs at the level of the lymphocyte, since 
preincubation of the HEV with the mAb did not cause 
inhibition of binding.
Comparative immunoprécipitation studies with the 
mAb Hermes-1, NKI-P1 and NKI-P2 confirmed the notion 
that these mAb recognize similar Ag. Like NKI-P1 and 
NKI-P2, Hermes-1 was also found to immunoprecipitate 
a major band of 90 kDa and several additional bands 
with a much lower intensity at approximately 120, 150,
TABLE I
E ffec ts  o f m Ab on homotypic aggregation o f J Y  cellsa
mAb
Aggregated Cells (%)
t —  35 min t = 70 min
SPV-L7 0 15
NKI-L15 0 10
NKI-Pl 70 95
NKI-P2 80 95
CLB-54 0 5
W 6/32 15 40
Medium 20 50
a mAb were added to JY cells. After 35 and 75 min incubation at 37°C, 
the percentage of aggregated cells w as determined using a light micro­
scope.
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Figure 1 . SDS-PAGE analysis of NKI-P1 and NKI-P2 im m unoprecipi­
ta te s  from a laBMabeled lysate of hum an monocytes. H um an monocytes 
w ere  obtained by centrifugal élutriation and directly surface-labeled by 
th e  lactoperoxidase method. After solubilization [1% NP-40) and  preclear­
ing, the lysate was used for immunoprécipitation with NKI-P2 (lane  A), 
NKI-P1 [lane B), SPV-L10 (lane C), SPV-L7 (lane D), norm al mouse IgG 
(lane  E). Analysis was performed by SDS-PAGE under reducing condi­
tio n s  on a  continuous gradient gel (5 to 12.5%).
200^
. : : ' .  <: 1 5. :r
I * : V.
.• I
: *3 . 1
. u  r*
I.
m
" M W ^ É Ê i i
97 .
6 9 ,
4 5 -
F tg u re 2 , SDS-PAGE analysis of NKI-P1, NKI-P2 and Hermes-1 im ­
munoprecipitates from a 125I-labeled lysate of hum an  monocytes. Mono­
cytes were radiolabeled by the iodogen method and the lysate w as divided 
into equal parts  for im munoprécipitation with norm al mouse IgG (la n e  
A), NKI-P1 (lane  B), Hermes-1 (Jane C} and NKI-P2 (lane D ). The im m u­
noprecipitates were analyzed on a continuous gradient gel of 6 to 8 u n d e r  
reducing conditions.
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TABLE II
Inhibition o f  adhesion  o f peripheral blood lym p h o cy te s  to H E V  by
NKÏ-P1 and NKI-P2
mAb
(Ag)
% inhibition of lymphocyte b ind ing  to
HEV (X ± SE)°
mAb added to 
lymphocytes
mAb added to 
frozen sections 
(HEV)
15D9 (T200) - 2  ± 6 1 ±  6
NKI-P1 (gp90) 51 ± 6 —2 dz 9
NKI-P2 (gp90) 56 ± 5 7 ± 8
SPV-L7 (LFA-1 «) 59 ± 5 9 ±  11
a Mean ± SE of three independent experiments.
and 180 kDa from a lysate of human monocytes (Fig. 2). 
Moreover, one dimensional peptide mapping of the 90 
kDa products with V8 protease resulted in sim ilar proteo­
lytic fragments (Fig. 3A, lane A, B, and C) that, as ex­
pected, are clearly distinct from those of LFA-/3 (Fig. 3B, 
lane D and E). Additional evidence was obtained from 
sequential immunoprécipitation studies. Preclearing of a 
lysate with the Hermes-1 antibody and vice versa resulted 
in a  strong reduction (>95%) of the immunoprecipitated 
material obtained with mAb NKI-P1 or NKI-P2 (data not 
shown). From these data we conclude th a t gp90 is ho­
mologous to the so-called LHR and distinct from the 0- 
chain of LFA-1. Crossblocking studies with NKÏ-P1, NKI- 
P2, and Hermes-1 showed that the former two mAb rec­
ognize overlapping epitopes on the gp90 molecule distinct
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Figure 3. One dim ensional peptide map analysis of gp90, the Hermes- 
1 LHR and the  /3-chain of LFA-1. 125I-labeled Ag were precipitated from  
h u m an  monocytes and ru n  on a SDS-polyacrylamide gel. Bands with the  
appropriate polypeptides were cut out and subjected to S. aureus V8 
protease. The proteolytic fragm ents were ru n  on a second polyacrylamide 
(15%) for analysis. A, NKI-P2 gp90 {lane A), Hermes-1 LHR (Zane B), NKI- 
P1 gp90 {lane C). B, In a  separa te  experiment* NKI-P1 gp90 (lane D) w as 
compared with LFA-1/î (lane  E).
from the epitope recognized by Hermes-1 (data not 
shown).
gp90 shows a broad tissue distribution. The cell and 
tissue distribution of gp90 was studied using NKI-P1, 
NKI-P2, and Hermes-1 mAb in immunohistochemical, 
immunofluorescence, and immunoprécipitation studies. 
The immunohistochemical studies were performed on
frozen tissue sections of normal human organs. gp90 
was found to be expressed in the cytoplasm and on cell 
membranes of a variety of cells in lymphoid and nonlym­
phoid tissues (Table III). In lymphoid tissues, a high 
expression of the gp90 Ag was observed on most cells of 
both the B and T cell lineage as well as on macrophages, 
on Interdigitating and follicular dendritic cells, and on 
vascular endothelium. In addition, the mucosal epithe­
lium of the tonsil stained positive. In accordance with 
previous reports on the expression of the Hermes-1 LHR 
on normal lymphoid cells (5, 15), most germinal center 
cells and cortical thymocytes which are nonrecirculating 
lymphocytes were gp90 low or negative. In most of the 
nonlymphoid tissues tested, we observed staining of fi­
broblasts, endothelial cells, and macrophage-like cells, 
including the alveolar macrophages of the lung and Kupf- 
fer cells of the liver. Staining of epithelial cells was 
consistently found in the mucosa of tonsils, the epider­
mis, the salivary gland, and the pancreas, whereas intes­
tinal epithelium, hepatocytes, bile duct epithelium, tu ­
bular epithelial cells in kidney, as well as other epithelia 
tested were negative. Although staining with NKI-P1 and 
NKI-P2 was stronger than that obtained with Hermes-1, 
qualitative differences between the three mAb were not 
found. Immunofluorescence studies with NKI-P1, NKI- 
P2, and Hermes-1 likewise showed that the Ag recognized 
by these mAb are widely distributed. Positive staining 
was obtained on normal hemopoietic cells including lym- 
pho-, mono-, granulo-, and erythrocytes, promonocytic 
(U937) and lymphoid cell lines (JY), and tumor cell lines 
of nonhemopoietic origin, including T24 bladder carci­
noma, OVCAR-4 ovarium carcinoma, U-87MG glioblas­
toma, and A375 and M l4 melanoma cell lines (Fig. 4).
To exclude the possibility that the apparently broad 
tissue distribution of gp90 was due to cross-reaction with 
shared epitope(s) on unrelated molecule(s), comparative 
immunoprécipitation studies using a panel of cell lines 
were performed. The results shown in Figure 5 demon­
strate that the major band with an m.w. of approximately 
90,000 could be precipitated from most cell lines tested. 
Interestingly, we observed a marked heterogeneity in 
m.w. and the amount of the various polypeptides immu­
noprecipitated from the different cell lines. For example, 
the mamma-carcinoma cell lines T47D, MCF-7, and ZR- 
75 (Fig. 5B, lanes 3, 4, and 5) lack the 90-kDa molecule 
but express several higher m.w. polypeptides. From these 
data we conclude that the molecules recognized by NKI- 
P1 and NKI-P2 are identical to the Hermes-1 LHR and
TABLE III
Distribution of gp90 in norm ai h u m an  tissues“
Peripheral blood Lymphocytes, monocytes, granulocytes,
erythrocytes (thrombocytes negative) 
Lymphoid tissues (thymus, T and B lymphocytes, with the excep- 
lymph node, tonsil, appen- tion of cortical thymocytes and ger- 
dix, spleen) minal center ceils, macrophages, in ­
terdigitating and follicular dendritic 
cells
Epithelial tissues Keratinocytes of epidermis, mucosal
epithelium in tonsil, epithelium in 
salivary gland and pancreas 
Other Vascular endothelium, dendritic cell,
smooth muscle and fibroblast-like 
cells in many organs, Kupffer cells in 
the liver, alveolar macrophages in the 
lung, some fibers in ECM
“ Tissues tested: thymus, lymph nodes, tonsils, spleen, intestine, sali­
vary gland, pancreas, thyroid, adrenal gland, lung, liver, kidney, heart 
and skeletal muscle, and skin.
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are heterogeneously expressed by many cells of both 
hemopoietic and nonhemopoietic origin.
DISCUSSION
A central step in lymphocyte recirculation and homing 
is the migration of lymphocytes from the blood into the 
surrounding tissues via the wall of HEV (5, 18, 19). This 
migration is thought to involve tissue specific adhesion 
of lymphocytes to the endothelial lining of HEV via LHR 
expressed on the lymphocyte cell surface (5, 6, 8, 15, 17). 
The important role of LHR in lymphocyte homing was 
initially inferred from functional studies of lymphocyte 
migration in vivo (20-22) and of lymphocyte-HEV bind­
ing in vitro (5, 17, 20-23). More recently, the mAb Mel- 
14 described by Gallatin et al. (24) and the mAb Hermes- 
1/3 (8, 15) described by Jalkanen et al. have defined a 
set of 90-kDa murine and human LHR glycoproteins.
We found th a t the gp90 molecule identified by the novel 
mAb, NKI-P1 and NKI-P2, is homologous to the human 
Hermes-1 LHR and distinct from the /?-chain of LFA-1. 
This conclusion is based on immunoprécipitation and 
peptide mapping studies comparing the gp90 band pre­
cipitated by NKI-P1 and NKI-P2 with that obtained with 
anti-LFA-1 /? and Hermes-1, Although we used human 
monocytes in these initial experiments, NKI-P 1 and NKI- 
P2 also recognize a functional epitope on the LHR as it is 
expressed on lymphocytes. This is evident from our tissue 
distribution studies showing identical staining patterns 
for NKI-P1, NKI-P2, and Hermes-1 as well as from the 
functional studies demonstrating inhibition of lympho­
cyte adhesion to HEV by NKI-P1 and NKI-P2. The capacity 
of NKI-P 1 and NKI-P2 to inhibit binding of lymphocytes 
to HEV indicates tha t these antibodies recognize an epi­
tope on the LHR distinct from Hermes-1 since the latter 
antibody is noninhibitory (15). This conclusion is con­
firmed by our crossblocking studies.
As is shown by the immunohistochemical, immunoflu­
orescence, and immunoprécipitation studies, we ob­
served tha t the gp90 molecule recognized by NKI-P 1 and 
NKI-P2 (but also by Hermes-1) is rather widely distributed 
among both hemopoietic and nonhemopoietic cells, and 
in this respect there is some resemblance to ICAM-1, a 
recently described cell-adhesion molecule and counter­
structure of LFA-1 (2, 7, 25). Although this molecule has 
approximately the same m.w., tissue distribution and 
biochemical studies showed that it is clearly distinct from 
gp90 (our unpublished observations). Interestingly, how­
ever, it has recently become clear that the Hermes-1 LHR, 
Pgp-1, and the extracellular matrix receptor type III 
(ECMR III) might all be similar to CD44. Mackay et al, 
showed that Pgp-1 has an m.w. of approximately 94,000 
and is homologous to CD44 (26). Wayner, Carter, and 
Gallatin (27) observed that the 90-kDa phosphorylated 
transm em brane molecule ECMR III binds collagen and is 
homologous to the Hermes-1 LHR. Data presented in the 
CD44 workshop recently held at the 4th International 
Conference on hum an leykocyte differentiation antigens 
(Vienna, February 21-25, 1989) supported the notion 
that these Ag are related and may all fall within the CD44 
cluster.
The Ag recognized by NKI-P1, NKI-P2, and Hermes-1 
are also expressed on a spectrum of nonhemopoietic tu­
mor cell lines including bladdercarcinoma, ovariumcar- 
cinoma, mammacarcinoma, glioblastoma, and melanoma
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Figure 4. Expression of LHR and LFA-1 on various h u m a n  cell-line cells, monocytes and  erythrocytes. T he  tum or cell-line cells (A375, M l 4, 
OVCAR-4, T24, U87MG) were treated with EDTA to obtain  single-cell suspensions. After washing, these cells, U937, monocytes and erythrocytes 
were incubated with mAb (ascites in a 500-fold dilution) followed by incubation with FITC conjugated goat anti-m ouse IgG F(ab)2. Fluorescence w as  
measured with a FACS. As negative control antibody, an  anti-idiotype antibody (S6) (IgGl) was used.
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F ig u re s .  SDS-PAGE analysis of NKI-P 1 and  
NKI-P2 immunoprecipltates from various cell line 
lysates. Cells were labeled with l2SI using the lac- 
toperoxidase method. Single cell suspensions of 
the adherent cell lines, were obtained after t re a t­
ment with EDTA. The immunoprecipitates were 
analyzed under reducing conditions on a 5 to 15% 
gradient polyacrylamide gel. A ,  lane 1, M14 m ela­
noma; lane 2, OVCAR-4 ovarian carcinoma; ia n e  
3, T24 bladder carcinoma. B, lane 1 ,  A375 m ela­
noma; lane 2, HBL100 normal human m am m ary 
cell line; lane  3, T47D mammacarcinoma; iane 4 t 
MCF-7 mammacarcinoma; lane 5, ZR-75 m am ­
macarcinoma.
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cell lines and display a consistent m,w. heterogeneity in 
these different cell types. This expression on tumor cell 
lines cannot be attributed to culture conditions inasmuch 
as expression was also observed in several native tumors 
(our unpublished observation). It will be im portant to 
determine if the gp90 and related higher m.w, molecules 
on nonhemopoietic cells can also mediate cell adhesion 
to endothelium and/or play a role in other adhesive cell­
cell and cell-matrix interactions. If so, the Hermes-1 LHR
and related molecules on nonlymphoid cells would con­
stitute a novel family of adhesive glycoproteins. As was 
recently described for LHR expression in non-Hodgkin’s 
lymphoma in mouse (28) and man (29), expression of 
these molecules on nonhemopoietic tumor cells might 
also be related to their metastatic potential. In this con­
text, it is of interest that certain nonlymphoid murine 
tumors show tissue-specific adhesion to capillary endo­
thelium in vitro (30), and correspondingly, preferential
856 TISSUE DISTRIBUTION OF THE HERMES-1 LHR
metastasis in vivo (31).
All three mAb immunoprecipitate small amounts of 
120, 150, and 180 kDa glycoproteins in addition to gp90. 
A similar observation was recently reported by Jalkanen 
et al., who described a subset of Ag recognized by Hermes- 
1 and -3 with a molecular mass of 180 to 200 kDa (32). 
Interestingly, we found that all three, bu t not the normal 
mammary gland cell line HBL100, lacked expression of 
the major 90 kDa polypeptide present in all other cell 
lines tested. Pulse-chase experiments of Jalkanen et ah 
indicated that a precursor of 76 kDa appears to be proc­
essed to a 90 kDa and a 180 to 200 kDa form, the latter 
by addition of chondroitin sulfate side chains. The addi­
tional bands of 120 and 150 kDa (Fig. 2) identified in our 
experiments might represent molecules with less chon­
droitin side chains because Jalkanen et al. observed sim­
ilar bands after incomplete digestion of the 180 to 200 
kDa band with chondroitinase-ABC. It should be noted 
that different cell types were used in our biochemical 
studies and that the differences observed may reflect 
m.w, heterogeneity of the high m.w. glycoproteins similar 
to that of the major 90 kDa band. Thus far it is not clear 
whether the absence of the 90 kDa polypeptide observed 
in the mammacarcinoma cell-line cells must be ascribed 
to a lack of gp90 biosynthesis, or to an  almost complete 
conversion of the 90 kDa polypeptide to the higher m.w. 
forms. Biosynthesis experiments are underway to clarify 
this observation.
A still unresolved question is the biochemical basis of 
organ-specific lymphocyte HEV binding. Minor modifi­
cations of the LHR adhesion receptors or their ligands 
might convey tissue specificity. Alternatively, tissue 
specificity could be the net result of multiple adhesion- 
molecule interactions. Thus, several types of molecules 
have been described which are involved in the adhesion 
of lymphocytes to endothelium. Among these are LFA-1 
(6, 33) and VLA-4 (34), both members of the integrin 
superfamily. Furthermore, it has become clear that Elam- 
1 and Mel-14, which mediate leukocyte-endothelial cell 
interactions, are closely related adhesion proteins (35, 
36).
Finally, the fact that NKI-P1 and NKI-P2 were raised 
through immunization with immunoprecipitated LFA-1 
family molecules needs comment. This result could be 
explained by the possibility that these mAb recognize an 
epitope shared by gp90 and LFA-1. Alternatively, it could 
indicate that gp90 and LFA-1 were somehow associated 
in the immunoprecipitate used for immunization. Al­
though at present we cannot definitively discriminate 
between either of these two possibilities, our observation 
that NKI-P1 and NKI-P2 sometimes coprecipitate small 
amounts of LFA-1 (unpublished observation), as well as 
the demonstration that LFA-1 is also involved in lympho­
cyte adhesion to HEV, might favor the latter explanation. 
Additional studies are required to clarify this point.
In conclusion, our data demonstrate tha t gp90 is ho­
mologous to the Hermes-1 LHR and tha t th is glycoprotein 
is expressed on hemopoietic as well as on a number of 
nonhemopoietic tissues and cell lines. Although the func­
tion of these molecules is at present incompletely under­
stood, they might represent a novel family of adhesion 
molecules involved in (tissue specific) cell-cell and cell- 
matrix interactions.
Note added  in proof. During processing of this paper 
it was reported th a t indeed CD44 is homologous to Pgp-1 
and the hum an Hermes-1 LHR (37). Furthermore, cloning 
of the gene encoding the Hermes-1 LHR showed th a t this 
molecule is related to the cartilage proteoglycan core and 
link proteins (38, 39).
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